Teva Pharmaceutical's market cap is currently $19.94B. The company's EPS TTM is $-1.447; its P/E ratio is ―; Teva Pharmaceutical is scheduled to report earnings on January 29, 2025, and the estimated EPS forecast is $0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 16.54B	$ 15.85B	$ 14.93B	$ 15.88B	$ 16.66B
Gross Profit	$ 8.06B	$ 7.65B	$ 6.97B	$ 7.59B	$ 7.72B
Operating Income	$ -303.00M	$ 433.00M	$ 2.80B	$ 3.20B	$ 3.05B
EBITDA	$ -303.00M	$ 1.57B	$ -874.00M	$ 4.41B	$ -2.09B
Net Income	$ -1.64B	$ -559.00M	$ -2.35B	$ 417.00M	$ -3.99B
Balance Sheet
Cash & Short-Term Investments	$ 3.30B	$ 3.23B	$ 2.80B	$ 2.17B	$ 2.18B
Total Assets	$ 39.33B	$ 43.48B	$ 44.01B	$ 47.67B	$ 50.64B
Total Debt	$ 18.08B	$ 20.15B	$ 21.56B	$ 23.46B	$ 26.40B
Net Debt	$ 14.78B	$ 16.93B	$ 18.76B	$ 21.29B	$ 24.22B
Total Liabilities	$ 33.61B	$ 35.35B	$ 35.31B	$ 36.42B	$ 39.58B
Stockholders' Equity	$ 5.38B	$ 7.51B	$ 7.90B	$ 10.28B	$ 10.03B
Cash Flow
Free Cash Flow	$ 749.00M	$ 842.00M	$ 1.04B	$ 236.00M	$ 638.00M
Operating Cash Flow	$ 1.25B	$ 1.37B	$ 1.59B	$ 798.00M	$ 1.22B
Investing Cash Flow	$ 792.00M	$ 968.00M	$ 656.00M	$ 1.52B	$ 863.00M
Financing Cash Flow	$ -1.79B	$ -1.91B	$ -1.49B	$ -2.17B	$ -1.89B

Currency in USD

Teva Pharmaceutical Earnings and Revenue History

Income Statement >

Teva Pharmaceutical Debt to Assets

Balance Sheet >

Teva Pharmaceutical Cash Flow

Cash Flow >

Teva Pharmaceutical Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing